Silver Book Fact

Stem Cell Therapy Study Shows Improved Motor Function in Parkinson’s

Fact image

Preliminary Report on the Safety and Tolerability of Bone Marrow-Derived Allogenic Mesenchymal Stem Cells Infused Intravenously in Parkinson’s Disease Patients; 2019. http://indexsmart.mirasmart.com/AAN2019/PDFfiles/AAN2019-003060.pdf. Accessed June 11, 2019

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • A treatment that delayed the age of onset of Alzheimer’s disease by five years would reduce the proportion of Americans age 65 and older with the disease from 10% to…  
  • If an Alzheimer’s disease treatment breakthrough that delayed the age of onset by 5 years was introduced in 2015, by 2050 Medicare costs for people with the disease would be…  
  • Research shows that use of donepezil leads to a 4-fold increase in drug costs; however, it significantly lowers overall medical costs, reducing medical treatment and prescription drug costs by $3,891…  
  • Stem Cell Therapy Study Shows Improved Motor Function in Parkinson’s
     
  • Valuing a QALY at $175,000, new drugs that would produce a 5-year delay in Alzheimer’s disease onset for all new cases between 2010 and 2050 would yield a benefit of…